Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $86,644 | 19 | 85.7% |
| Travel and Lodging | $11,269 | 25 | 11.1% |
| Food and Beverage | $1,862 | 19 | 1.8% |
| Honoraria | $1,320 | 1 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $66,335 | 50 | $0 (2020) |
| CSL Behring | $25,120 | 5 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $4,144 | 1 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $3,466 | 4 | $0 (2017) |
| Eli Lilly and Company | $1,800 | 1 | $0 (2021) |
| Kowa Pharmaceuticals America, Inc. | $229.90 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,300 | 1 | CSL Behring ($4,300) |
| 2022 | $4,000 | 1 | CSL Behring ($4,000) |
| 2021 | $1,800 | 1 | Eli Lilly and Company ($1,800) |
| 2020 | $19,116 | 6 | CSL Behring ($9,320) |
| 2019 | $11,075 | 11 | Amgen Inc. ($11,075) |
| 2018 | $30,147 | 19 | Amgen Inc. ($22,570) |
| 2017 | $30,656 | 25 | Amgen Inc. ($27,190) |
All Payment Transactions
64 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $4,300.00 | General |
| 03/16/2022 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $4,000.00 | General |
| 09/29/2021 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $1,800.00 | General |
| 12/23/2020 | CSL Behring | — | Honoraria | Cash or cash equivalent | $1,320.00 | General |
| 11/13/2020 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $5,500.00 | General |
| 03/11/2020 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $8,000.00 | General |
| 02/25/2020 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $4,144.00 | General |
| 02/25/2020 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $35.53 | General |
| Category: Cardiovascular | ||||||
| 02/21/2020 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $116.50 | General |
| Category: Cardiovascular | ||||||
| 12/02/2019 | Amgen Inc. | — | Food and Beverage | Cash or cash equivalent | $165.41 | General |
| 10/09/2019 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $4,400.00 | General |
| 10/09/2019 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| 10/09/2019 | Amgen Inc. | — | Travel and Lodging | Cash or cash equivalent | $2,152.51 | General |
| 09/12/2019 | Amgen Inc. | — | Travel and Lodging | In-kind items and services | $159.33 | General |
| 09/12/2019 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $46.97 | General |
| 09/12/2019 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $46.97 | General |
| 09/12/2019 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $46.97 | General |
| 09/11/2019 | Amgen Inc. | — | Travel and Lodging | In-kind items and services | $1,022.78 | General |
| 09/11/2019 | Amgen Inc. | — | Travel and Lodging | In-kind items and services | $164.33 | General |
| 09/11/2019 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $120.13 | General |
| 10/05/2018 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $7,150.00 | General |
| 10/05/2018 | Amgen Inc. | — | Travel and Lodging | Cash or cash equivalent | $878.93 | General |
| 10/02/2018 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $77.87 | General |
| Category: Cardiovascular | ||||||
| 09/06/2018 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $149.82 | General |
| 09/06/2018 | Amgen Inc. | — | Travel and Lodging | In-kind items and services | $73.12 | General |
About Dr. Alan Tall, M.D
Dr. Alan Tall, M.D is a Internal Medicine healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/07/2007. The National Provider Identifier (NPI) number assigned to this provider is 1275673782.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Tall, M.D has received a total of $101,095 in payments from pharmaceutical and medical device companies, with $4,300 received in 2024. These payments were reported across 64 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($86,644).
Practice Information
- Specialty Internal Medicine
- Location New York, NY
- Active Since 02/07/2007
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1275673782
Products in Payments
- Repatha (Biological) $17,151
- MK-0859 (Drug) $3,335
- Livalo (Drug) $229.90
- JANUVIA (Drug) $130.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in New York
Dr. Stephen Saletan, M.d, M.D
Internal Medicine — Payments: $2.7M
Michael Schuster, Md, MD
Internal Medicine — Payments: $2.1M
Dr. Ziad Ali, Md Dphil, MD DPHIL
Internal Medicine — Payments: $1.7M
Dr. James Underberg, Md, MD
Internal Medicine — Payments: $1.5M
Dr. Ricky Hsu, Md, MD
Internal Medicine — Payments: $1.2M
Gail Roboz, Md, MD
Internal Medicine — Payments: $1.1M